Key result
Hemodynamic support, sequential blockade, and adrenalectomy resolve pheochromocytoma-induced Takotsubo and cardiogenic shock.
Why the study?
Phaeochromocytoma classically presents with hypertension, making presentation with cardiogenic shock from phaeochromocytoma-induced Takotsubo cardiomyopathy extremely rare, requiring clinical awareness for early identification and management.
Case Report (n=1)
No
Phaeochromocytoma-induced Takotsubo cardiomyopathy can present with cardiogenic shock and requires early identification, hemodynamic support, and sequential alpha/beta blockade prior to surgical resection.
Supports considering sequential alpha/beta blockade plus support before adrenalectomy in phaeochromocytoma Takotsubo shock; hypothesis-generating pending controlled data.
Background: Phaeochromocytoma, on its own, is a rare endocrine condition. Patient that presents with cardiogenic shock as a result of phaeochromocytoma-induced Takotsubo cardiomyopathy is even rarer, as phaeochromocytoma classically presents with hypertension. Clinical awareness and understanding of this disease entity is important for early identification and appropriate management of this endocrine emergency. Case presentation: A 39-year-old woman presented with one day history of repeated vomiting associated with epigastric pain. Her condition deteriorated rapidly with acute cardiac and renal failure with cardiogenic shock after intravenous fluid infusion, requiring high flow oxygen and high dose inotropic support in intensive care unit. Subsequent workup confirmed diagnosis of phaeochromocytoma-induced Takotsubo cardiomyopathy. Her condition of cardiomyopathy had been tied over by combined effort of inotropic support, use of intra-aortic balloon pump and intravensous fluid in the acute phase for haemodynamic stabilization. Her renal function was normalized on day 3 and left ventricular systolic function was normalized on day 10. Alpha and beta blockade were sequentially added and she underwent adrenalectomy with peri-operative infusion of magnesium sulphate. Post-operatively, she had an uneventful course and was able to wean off anti-hypertensive medications. Conclusion: Phaeochromocytoma presenting with cardiogenic shock is a very uncommon clinical condition, but its early identification is important for relevant management strategies. Through illustration of this clinical case with special highlight of her young age, tachycardia and clinical features of Takotsubo cardiomyopathy, this clinical experience can be shared for lifesaving management.
No takes yet. Share an insight, caveat, or question.
Alice et al. (2024) conducted a case report in Phaeochromocytoma-induced Takotsubo cardiomyopathy with cardiogenic shock (n=1). Hemodynamic support, sequential alpha and beta blockade, and adrenalectomy was evaluated. A 39-year-old woman with phaeochromocytoma-induced Takotsubo cardiomyopathy and cardiogenic shock was successfully treated with hemodynamic support, sequential alpha and beta blockade, and adrenalectomy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: